MEBOT

MEBOT Intelligent Technology (Suzhou) Co., Ltd. specializes in developing wearable exoskeleton robots for industrial, consumer, and potential healthcare applications. Founded by a doctoral team led by Professor Wei Wei from Soochow University and Professor Lin Xichuan from UESTC, the company has accumulated over 100 patent applications with more than 50 patents granted.

Company Overview

MEBOT emerged from academic research that began assembling its core R&D team as early as 2008. The company positions itself as one of China’s early entrants in exoskeleton robotics, with R&D personnel comprising over 60% of its workforce. Based in Suzhou, MEBOT has developed proprietary technologies across mechanical systems, control algorithms, and human-machine interfaces.

The company completed its Series A funding round in June 2023, raising tens of millions of RMB from investors including Shenqi Haohui Fund and Suzhou High-Speed Rail Xincheng Fund. These funds have been directed toward expanding product lines, reducing manufacturing costs, and exploring consumer market applications.

Core Products

MEBOT has developed multiple exoskeleton product series targeting different use cases:

Wasp Series (Passive Lumbar Exoskeleton)

A non-powered waist support system designed for logistics workers, assembly line operators, and emergency responders. The passive design requires no battery and provides mechanical assistance during lifting tasks.

Swallow Series (Powered Lumbar Exoskeleton)

An active lumbar assistance system capable of supporting loads exceeding 30 kg. The powered design incorporates sensors and motors for dynamic assistance during heavy lifting in challenging environments.

Black Bear Series (Powered Lower Limb Exoskeleton)

Active lower limb exoskeleton targeting industrial and potentially medical applications. Features integrated sensing for gait detection and powered assistance during walking and load carrying.

Snow Ape Platform (Lower Limb Development Platform)

A research-oriented exoskeleton platform integrating multiple sensor types including EMG, EEG, and voice control interfaces. Currently deployed at several Chinese universities and research institutions for academic development.

Green Ant Series (Heavy Load Exoskeleton)

Lower limb exoskeleton designed for extreme payload capacity exceeding 100 kg. Features rapid donning (under 1 minute) and targets emergency rescue, field operations, and outdoor activities.

Consumer Lower Limb Exoskeleton

Lightweight exoskeleton weighing under 2 kg developed in partnership with Pathfinder Group for hiking and outdoor applications. Launched in December 2024, this product targets the emerging consumer wearables market.

Technology & Innovation

MEBOT’s core technological achievement is its proprietary “human-machine coupled joint with integrated sensing functionality.” Unlike conventional exoskeleton architectures using separate motor, reducer, and driver components, MEBOT’s integrated joint design combines sensors and actuators in a compact package.

Key technical specifications include:

• Output power density: 150 Nm/kg
• Multiple assistance level settings for dynamic power adjustment
• Ergonomic design following human factors engineering principles
• Quick-release mechanisms for swappable power units

The company employs IoT and AI technologies through its “Exoskeleton + Cloud Brain” platform. This cloud computing system collects user behavior data and device telemetry, enabling continuous algorithm optimization based on real-world usage patterns. Machine learning models trained on extensive user data provide personalized gait assistance tailored to individual movement characteristics.

Market Presence

MEBOT’s products have been deployed across multiple industries:

Industrial Logistics: The company’s earliest application sector, starting with partnerships in retail logistics since 2017. Current customers include major bulk cargo ports, automotive logistics companies, and warehouse operators.

Consumer Outdoor: Partnership with Pathfinder Group (探路者) resulted in a hiking exoskeleton launched in December 2024. The product gained visibility at scenic spots including Mount Tai and Enshi Grand Canyon, featuring automatic gait mode switching and hill climbing assistance.

Home Services: Collaboration with 58 Daojia providing exoskeleton equipment for moving services.

Emergency Response: Products targeting first responders and field operations requiring heavy lifting in challenging conditions.

Key Milestones

• 2008: Core R&D team formation begins
• 2017: Initial industrial logistics deployment and collaboration
• 2023: Series A funding completed (tens of millions RMB)
• 2024: Consumer hiking exoskeleton launched with Pathfinder
• 2024: Products featured at multiple Chinese scenic areas

Frequently Asked Questions

Does MEBOT produce medical rehabilitation exoskeletons?

MEBOT’s current product portfolio primarily targets industrial and consumer applications. While the company’s technology platform has potential healthcare applications, no products have obtained NMPA medical device registration as of early 2026. The company’s Snow Ape platform serves as a research tool at academic institutions exploring rehabilitation applications.

Where is MEBOT headquartered?

MEBOT is headquartered in Suzhou, Jiangsu Province, China. The company’s full legal name is MEBOT Intelligent Technology (Suzhou) Co., Ltd.

What industries use MEBOT exoskeletons?

MEBOT exoskeletons are deployed in industrial logistics, automotive manufacturing, home moving services, emergency response, and outdoor recreation. The company’s consumer hiking exoskeleton gained popularity at tourist destinations in late 2024.